StudyFinder
Sightline: Determination and Validation of Lung EpiCheck a Multianalyte Assay for Lung Cancer Prediction. A Case-Control Study.
Recruiting
The main purpose of the study is to collect blood samples and medical information to help Nucleix in the development of an investigational test that aims to differentiate between individuals at high risk with and without lung cancer.
Male or Female
18 years and over
Inclusion Criteria:
• Current or past smokers, with at least 20 pack-years
• People who have with either a high suspicion for lung cancer, with surgery planned for biopsy or removal
• People who have lung cancer that hasn't been treated yet
Exclusion Criteria:
• People who have diagnosis or treatment of any previous cancer, including lung cancer, in the past 5 years, except for fully resected non-melanoma skin cancer or fully-resected carcinoma in situ of the cervix
• Current lung cancer is known to be stage III or IV by pathology.
• People having regular screening to monitor a lung nodule
Cancer, Respiratory System
Lung Cancer Screening, Clinics and Surgery Center (CSC)